12 start-ups of the DACH region proceed to the Regional Selection of EIT Health Catapult

EIT Health RIH Germany-Switzerland has selected 12 start-ups to continue their EIT Health Catapult journey and compete in the Regional Selection, where an expert jury will select 2 best-of-the-best business concepts from each category: MedTech, Biotech and Digital Health.

EIT Health Catapult is a training and competition programme that boosts the development of top-notch European health start-ups (Biotech, MedTech and Digital Health) through exposure to leading experts and international investors.

Following the evaluation process, EIT Health RIH Germany-Switzerland has shortlisted 12 start-ups from Germany, Switzerland and Austria for the Regional Selection of this year’s EIT Health Catapult.

The 12 start-ups will present their projects in a pitch competition at the dHealth 2022 event on 25 May 2022 in Vienna and will be intensively examined by a jury of experts for their investment readiness.

The 6 start-ups that will be selected by the jury, 2 in each category, will proceed to the Catapult semi-finals later this year.

Let´s have a look at the selected start-ups!

Biotech category:

Ablevia biotech GmbH – Ablevia’s team envisions a future where the targeted removal of unwanted and disease-causing antibodies no longer imposes inefficient and stressful restrictions. Their mission is to develop therapeutics for the removal of unwanted and disease-causing antibodies.

PRAMOMOLECULAR GmbH – Based on its patent-pending platform technology, PRAMOMOLECULAR develops self-delivering siRNAs as drug candidates for the treatment of serious cancer and infectious diseases in lung and pancreas.

DEUS Health GmbH – DEUS uses a wide array of diagnostics to create an individualized profile for patients. With deep biomarker profiling, blood analysis and state-of-the-art imaging equipment, they collect more than 160GB of unique data. With the unique profile, they can approach patients´ health holistically and provide them with the best actionable recommendations.

Systasy Bioscience GmbH – Systasy´s pathway profiling services offer unmatched early-on knowledge of disease-related cellular mechanisms to revitalize drug development for genetically complex diseases.


MedTech category:

Freiburger Medizintechnik GmbH – Freiburger Medizintechnik´s mission is to provide the medical community with innovative technology for highly effective and simple infection control. Their technology is based on the Transient Spark Disinfection, a special form of cold plasma jet designed for application in dentistry.

Biome Diagnostics GmbH – Biome Diagnostics combines state-of-the-art microbiome diagnostics with AI to advance the field of personalized diagnostics and therapeutic approaches. In this way, the company aims to bring sound gut microbiome diagnostics into routine use.

Sedivention GmbH – At Sedivention, they believe that transformation of surgeries into interventions without the need for incision, trauma, and general anaesthesia is a huge medical need. They are working on new interventional devices to enable interventional treatments with the aim to make healthcare less invasive, less costly, and more accessible.

DaThera Consumer Health GmbH – DaThera Consumer Health aims to reduce pain, offer a better sleeping as well as be more relaxed and mobile after waking up. Their solution is also suitable for competitive athletes by allowing them to recover faster.


Digital health category:® by SOFY GmbH –®´s vision is to create a place, where all depressed people feel they are in good hands – empowering them to beat depression!

XUND Solutions GmbH – At XUND Solutions they believe that people, medicine and technology go hand in hand. Their medical device allows to build a digital health assistant that helps customers, patients and employees to understand their symptoms, receive reliable assessments on what could be causing them and take the right next steps.

deepeye Medical GmbH – deepeye empowers ophthalmologists with AI to provide individual therapy to patients suffering from retinal eye diseases like Age-related Macular Degeneration (AMD) and others with a prevalence of >12% in the European and US population, thus preventing the causes of more than 90% of blindness.

ReHub GmbH – Rehago enables millions of hemiplegic people worldwide to accelerate their return to independent living. With modern virtual reality games, they offer independent, affordable and motivating training to those affected and encourage them to regularly push themselves to their performance limits.


We wish you all the best of luck at the Regional Selection on 25 May!